Prolonged Treatment for Infected Abortion After Hospital Discharge.
Information source: Hospital de Clinicas de Porto Alegre
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Septic Abortion
Intervention: metronidazole and doxycycline (Drug)
Phase: Phase 4
Status: Terminated
Sponsored by: Hospital de Clinicas de Porto Alegre Official(s) and/or principal investigator(s): Ricardo F Savaris, MD, PhD, Principal Investigator, Affiliation: Hospital de Clínicas de Porto Alegre Adriani O Galão, MD, PhD, Principal Investigator, Affiliation: Hospital de Clínicas de Porto Alegre
Summary
Patients with infected abortion will be treated with dilatation and curettage, intravenous
antibiotics. The purpose of this study is to verify if it is necessary to keep the use of
oral antibiotics after hospital discharge.
Clinical Details
Official title: Prolonged Treatment for Infected Abortion After Hospital Discharge.
Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
Primary outcome: Hospital re-admission
Secondary outcome: minimal or absent vaginal bleedingwalking normally important decrease of pain no fever
Detailed description:
The use of 7-10 days of treatment for infected/septic abortion is not based on clinical
trials. A recent evidence showed that endometritis post cesarean section needs no treatment
after hospital discharge. The objective of this study is to verify if this finding also
applies to infected abortions.
After in hospital treatment, the patients will be randomized to the traditional treatment
(metronidazole and doxycycline) or to placebo until 10 days of treatment is completed. Active
follow-up will be done every 2 days, and the patient will be reevaluated at the end of
treatment.
Cure will be defined as the absence of fever, pain and bleeding. Failure of treatment will be
considered as the need for hospitalization or additional antibiotics.
Eligibility
Minimum age: 14 Years.
Maximum age: 50 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- History of intrauterine manipulation with contaminated objects.
- Vaginal secretion with fetid odor
- Presence of pus flowing through the cervical uterine
- Presence of peritonitis
- Leucocytosis (> 14,000 leucocytes/mL)
- Vasodilatation, bounding pulse and paradoxically warm periphery with tachycardia
(Heart rate> 110 bpm)
- Cyanosis and/or paleness
- tachypnea(> 30mpm)
- Arterial hypotension (SAP< 90mmHg)
- Oliguria
- Fever (> or = than 37,8°C)
Exclusion Criteria:
- Refusal to participate in the project
- Prior use of antibiotics within one week
- Known allergy to Doxycycline or Metronidazole
- Presence of tubo-ovarian abscess
Locations and Contacts
Hospital de Clínicas de Porto Alegre, Porto Alegre, RS 90035-003, Brazil
Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul 90035-003, Brazil
Additional Information
Related publications: Stubblefield PG, Grimes DA. Septic abortion. N Engl J Med. 1994 Aug 4;331(5):310-4. Review. Tamussino K. Postoperative infection. Clin Obstet Gynecol. 2002 Jun;45(2):562-73. Review. No abstract available. Turnquest MA, How HY, Cook CR, O'Rourke TP, Cureton AC, Spinnato JA, Brown HL. Chorioamnionitis: is continuation of antibiotic therapy necessary after cesarean section? Am J Obstet Gynecol. 1998 Nov;179(5):1261-6. Faro S. Postpartum endometritis. Clin Perinatol. 2005 Sep;32(3):803-14. Review. French LM, Smaill FM. Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001067. Review. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001 Apr 17;134(8):663-94. Review. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999 Sep 11;319(7211):670-4. Review.
Starting date: May 2006
Ending date: December 2007
Last updated: March 10, 2008
|